NOTICE For Investors In ABT: Lawsuit against Abbott Laboratories announced by Shareholders FoundationNewsfile Corp • 11/29/22
Abbott (ABT) Up 7.7% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 11/18/22
24-Month Data from Surmodics' TRANSCEND Trial Presented at VIVA 2022 ConferenceBusiness Wire • 11/02/22
ABT FINAL DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Abbott Laboratories Investors to Secure Counsel Before Important October 31 Deadline in Securities Class Action - ABTPRNewsWire • 10/31/22
ABT LAWSUIT ALERT: Levi & Korsinsky Notifies Abbott Laboratories Investors of a Class Action Lawsuit and Upcoming DeadlineNewsfile Corp • 10/31/22
7 ‘Strong Buy' Dividend Aristocrats That Blew Away Q3 Earnings Expectations24/7 Wall Street • 10/31/22